V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10017166 | 10068326 | 1.7 | 87.6 | null | null | 2018-11-03 | Avelumab | 02 | null | BENDAMUSTINE + RITUXIMAB | 100287119 |
| 10018584 | 10068327 | 1.7 | 83.8 | Palliative (P) | null | 2021-11-09 | Avelumab | 02 | N | DARATUMUMAB | 101088419 |
| 10021167 | 10068328 | 1.89 | 94.6 | null | 2016-08-15 | 2016-10-14 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101324634 |
| 10024439 | 10068329 | 1.62 | 56 | Curative (C) | 2021-08-07 | 2022-05-28 | RUXOLITINIB | N | N | RUXOLITINIB | 101353491 |
| 10028309 | 10068331 | 1.62 | 81 | 03 | 2020-09-21 | 2020-11-06 | Venetoclax | 02 | null | VENETOCLAX | 101306915 |
| 10030463 | 10068332 | 1.59 | 71.2 | null | 2021-05-18 | 2021-06-01 | Avelumab | 02 | null | VENETOCLAX | 100517013 |
| 10037048 | 10068333 | 1.69 | null | 03 | 2018-09-12 | 2018-09-26 | Avelumab | 02 | N | TRASTUZUMAB | 101344549 |
| 10037227 | 10068334 | 1.85 | 74.5 | null | null | 2021-03-07 | Avelumab | 02 | null | FLUOROURACIL + IRINOTECAN | 101371464 |
| 10042327 | 10068335 | 1.62 | 69.15 | Neo-adjuvant (N) | 2019-05-17 | 2019-08-06 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101033870 |
| 10043105 | 10068336 | 1.86 | 57.1 | null | 2017-11-27 | 2019-10-03 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101317416 |
| 10044381 | 10068337 | 1.58 | 75 | null | null | 2019-06-12 | Irinotecan + Modified De Gramont | N | null | FLUOROURACIL + IRINOTECAN | 100593323 |
| 10047815 | 10068339 | 1.75 | 92 | Palliative (P) | 2022-05-30 | 2022-05-30 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 101098508 |
| 10049798 | 10068340 | 1.68 | 73.5 | Curative (C) | null | 2021-02-03 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 100625952 |
| 10051750 | 10068341 | 0 | 72 | Palliative (P) | 2019-06-10 | 2019-10-18 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 100309116 |
| 10055637 | 10068343 | 0 | 88 | 03 | 2020-07-22 | 2020-07-22 | Venetoclax | 02 | N | VENETOCLAX | 101433600 |
| 10058477 | 10068345 | 1.67 | 63.4 | null | 2016-06-21 | 2016-08-05 | Avelumab | 02 | null | FLUOROURACIL + IRINOTECAN | 101737185 |
| 10064100 | 10068347 | 1.74 | 78.3 | null | 2019-06-27 | 2019-07-11 | Avelumab | 02 | null | DARATUMUMAB | 100807441 |
| 10070902 | 10068348 | 1.79 | 72 | null | 2018-09-24 | 2018-10-02 | DARATUMUMAB | 02 | null | DARATUMUMAB | 100591661 |
| 10072681 | 10068349 | 1.7 | 64.1 | null | 2021-11-13 | 2021-11-13 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100635331 |
| 10073652 | 10068350 | 0 | 54.02 | null | 2019-06-09 | 2020-02-09 | Avelumab | 02 | null | BENDAMUSTINE + RITUXIMAB | 101210565 |
| 10075178 | 10068351 | 1.74 | 83 | Palliative (P) | 2020-12-06 | 2021-03-19 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 101049512 |
| 10076213 | 10068352 | 1.61 | 71.6 | null | 2016-12-09 | 2016-12-15 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100544266 |
| 10085293 | 10068354 | 1.66 | 70.7 | null | 2021-04-06 | 2021-06-30 | CEMIPLIMAB | 02 | null | CAPECITABINE + OXALIPLATIN | 101221821 |
| 10087201 | 10068355 | 1.77 | 71.3 | Palliative (P) | 2019-09-20 | 2019-09-20 | Venetoclax | 02 | N | VENETOCLAX | 100557359 |
| 10091197 | 10068356 | 1.65 | 66.9 | Palliative (P) | 2021-01-03 | 2021-01-25 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 101301313 |
| 10094662 | 10068357 | null | 74.6 | Palliative (P) | 2020-03-23 | 2021-02-18 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 100723532 |
| 10097910 | 10068359 | 1.72 | null | Palliative (P) | 2021-06-29 | 2021-07-06 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101086136 |
| 10100653 | 10068360 | 1.7 | 78.9 | Palliative (P) | 2019-10-16 | 2021-04-20 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 101035928 |
| 10102958 | 10068362 | 1.68 | 62.3 | Palliative (P) | 2021-08-16 | 2021-10-19 | Venetoclax | 02 | null | VENETOCLAX | 101538390 |
| 10103476 | 10068363 | 1.69 | 70.1 | 03 | 2022-02-28 | 2022-03-22 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100440302 |
| 10114484 | 10068364 | null | 66.4 | 03 | null | 2021-03-25 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 100430739 |
| 10118194 | 10068365 | 1.83 | 46 | Palliative (P) | 2017-12-21 | 2019-09-25 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100899876 |
| 10121867 | 10068366 | 1.74 | 74.5 | null | null | 2020-05-11 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101375454 |
| 10124951 | 10068367 | 0 | 89.1 | null | 2021-01-15 | 2022-02-01 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100266071 |
| 10126275 | 10068368 | 1.62 | 56 | null | 2015-07-07 | 2017-12-16 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 101494062 |
| 10126468 | 10068369 | 1.65 | 69.3 | Adjuvant (A) | 2021-07-09 | 2021-07-31 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 100006212 |
| 10131685 | 10068370 | 1.7 | 55.4 | null | 2019-12-06 | 2019-12-08 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101420687 |
| 10133018 | 10068371 | 1.77 | 0 | Palliative (P) | 2019-08-09 | 2019-11-04 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101090201 |
| 10135790 | 10068372 | 1.65 | 98 | null | 2019-09-20 | 2019-10-28 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101571969 |
| 10138617 | 10068373 | 1.47 | 93.4 | null | 2017-05-28 | 2017-05-30 | CEMIPLIMAB | null | null | CEMIPLIMAB | 101005405 |
| 10140465 | 10068375 | 0 | 63.35 | Adjuvant (A) | 2017-11-17 | 2019-01-18 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100642987 |
| 10140587 | 10068376 | 1.76 | 66.8 | null | 2022-03-17 | 2022-03-19 | Avelumab | N | N | TRASTUZUMAB | 101591233 |
| 10141993 | 10068377 | 0 | 92 | Palliative (P) | 2019-04-27 | 2019-05-14 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100468665 |
| 10143751 | 10068378 | 1.61 | 77.2 | null | 2021-05-18 | 2021-09-25 | CEMIPLIMAB | 02 | null | CARBOPLATIN + GEMCITABINE | 100323751 |
| 10146407 | 10068380 | 1.7 | 61 | Palliative (P) | 2020-11-09 | 2020-11-18 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100737526 |
| 10153291 | 10068382 | 1.54 | 66.3 | null | 2016-04-22 | 2016-07-05 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100982627 |
| 10158411 | 10068384 | 1.73 | 55.4 | Adjuvant (A) | 2019-09-08 | 2019-09-18 | Venetoclax | 02 | N | VENETOCLAX | 101659045 |
| 10161709 | 10068385 | 1.79 | 56 | Palliative (P) | 2019-07-14 | 2020-10-02 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100645879 |
| 10164254 | 10068386 | 1.71 | 0 | null | null | 2021-06-05 | Avelumab | 02 | null | CEMIPLIMAB | 101460626 |
| 10168334 | 10068387 | 1.71 | 78 | null | 2021-10-26 | 2021-11-26 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101071948 |